InterValley Ventures is an early stage VC investing in breakthrough technologies linked to Artificial Intelligence. The AI^Human fund focuses on companies that generate, control and learn from unique data sources. Sectors include Healthcare, Life Sciences, AgTech, FoodTech, FinTech and EduTech. Our focus includes companies with deep technologies that improve AI performance and companies with hardware applications, including robotics, computer vision, sensor networks and drones. We also look generally at companies that have new, AI-enabled business models that are transforming industries. 80% of our capital will be deployed in Australia. Australian AI is World Class. Our universities are amongst the very best and boast one of the world’s highest acceptance rates for papers on AI. There are a plethora of excellent companies with valuations lower than China or Silicon Valley. These companies often receive large non-dilutionary grants & rebates. The AI^Human fund is globally backed by Japanese & other firms who are providing a combined anchor of $A10M, with a target fund size of $A200M. The multinational anchors value the rapid growth strategy of the fund: companies that are US similar, with attractive valuations, access to the very best deals, Japanese uplift, Asian uplift, and global exits. First close is expected in Q3, 2018. InterValley is strengthened by having New Frontier Capital Management as co-GP. NFCM is the strategic partner for Mizuho Securities PE Business and has global reach, including funds in China & India